SOTK Form 4: Director Carol O'Donnell Increases Ownership to 25,377 Shares
Rhea-AI Filing Summary
Carol O'Donnell, a director of Sono-Tek Corporation (SOTK), reported acquiring derivative securities on 08/21/2025. The filing shows acquisition of 7,018 Sono-Tek options with a $3.25 exercise price, exercisable beginning 08/21/2026 and expiring 08/21/2035. After the reported transaction, Ms. O'Donnell directly beneficially owned 25,377 shares of common stock. The Form 4 was signed 08/22/2025.
Positive
- Director acquisition: Carol O'Donnell acquired 7,018 options, showing insider purchase activity.
- Increased direct ownership: Beneficial ownership after the transaction is 25,377 shares, reported as direct ownership.
Negative
- None.
Insights
TL;DR: Insider acquired 7,018 options at $3.25, increasing direct ownership to 25,377 shares; routine disclosure with limited near-term market impact.
The filing documents a director-level acquisition of derivative securities rather than a sale, indicating an insider transaction that increases potential future share exposure. The options are priced at $3.25, exercisable from 08/21/2026 and expiring 08/21/2035, which provides a long exercise window. This is a standard Section 16 disclosure and does not include additional financial details or changes to outstanding equity beyond the ownership totals reported.
TL;DR: Director-level option acquisition disclosed; procedural compliance appears satisfied based on the Form 4 details provided.
The report identifies Carol O'Donnell as a director and shows an acquisition of 7,018 options on 08/21/2025. The Form 4 indicates direct ownership of 25,377 shares following the transaction and is signed 08/22/2025. The filing includes required exercise and expiration dates for the derivative securities. No governance actions, departures, or related-party transaction disclosures are included in this document.
FAQ
What did Carol O'Donnell report owning in the SOTK Form 4?
When was the transaction reported on the Form 4 for SOTK?
What are the exercise and expiration dates for the options reported?
What is the exercise price of the options acquired in the Form 4?
What is Carol O'Donnell's relationship to Sono-Tek as stated on the form?